HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
Clinical trials for HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) explained in plain language.
Never miss a new study
Get alerted when new HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT) trials appear
Sign up with your email to follow new studies for HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug hope for Kids' lung damage after transplant
Disease control TerminatedThis study tested the drug ruxolitinib for children and adults who developed early lung problems after a stem cell transplant. Lung issues like bronchiolitis obliterans (BO) can be serious and are often found too late. The goal was to see if adding ruxolitinib to standard treatme…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
Phase: PHASE2 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New antibiotic tackles tough infections in vulnerable patients
Disease control TerminatedThis study tested the antibiotic ceftolozane-tazobactam for serious Pseudomonas aeruginosa infections in people with blood cancers or who had a stem cell transplant. Participants received the drug through a vein for 10 to 14 days. Researchers tracked whether patients were alive a…
Matched conditions: HEMATOPOIETIC STEM CELL TRANSPLANT (HSCT)
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated May 13, 2026 15:59 UTC